Analytical Method Development and Validation of RP-HPLC Method For Estimation of Empagliflozin in Bulk and Pharmaceutical Dosage Form
Keywords:
Empagliflozin, RP HPLC, Anti Diabetic, Trifluoroacetic acid, MethanolAbstract
In this study, researchers aimed to develop and validate a reproducible and precise Reverse Phase High-Performance Liquid Chromatography technique for accurately estimating a chemical related to empagliflozin. The primary objective was to establish a method suitable for quality control of empagliflozin batches and its impurities. To achieve this, effective chromatographic separation has done by using two mobile phases: The mixture of 0.1 % Trifluoroacetic acid in Water and Methanol with flow rate 1.2 ml/min. The chromatographic separation was done by using a Phenomenex C-18, 250 mm X 4.6 mm, 5 µm. The results indicated successful chromatographic separation and accurate quantification. The proposed method demonstrated its efficacy for quality monitoring of bulk samples containing Empagliflozin, ensuring the reliability and consistency necessary for routine quality control purposes in the pharmaceutical industry
Downloads
References
Diabetes (type 2)-empaglifozin. Appraisal consultation document. NICE technology appraisal. 28 august 2014.
Nair S. Wilding JP: Sodium glucose cotransporter 2 inhibitors as a new treatment for diabetes mellitus. J Clin
. Chatwal g. R., anand s. K.; instrumental methods of chemical analysis; himalaya publishing house, mumbai; 11th edition, 2005, 1.1-1.2, 2.108-2,109, 2.151-2.153. Metab 2010; 95(1):34-42
. https://fjps.springeropen.com/articles/10.1186/s43094-021-00329-w
. https://www.jchr.org/index.php/JCHR/article/download/4317/2837/8034
. Sahu, Prafulla Kumar, Nageswara Rao Ramisetti, Teresa Cecchi, Suryakanta Swain, Chandra Sekhar Patro, and Jagadeesh Panda. “An overview of experimental designs in HPLC method development and validation.” Journal of pharmaceutical and biomedical analysis 147 (2018): 590-611.
. British pharmacopoeia, 1993, volume ii, 180-190.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.